Cornercap Investment Counsel Inc I Teos Therapeutics, Inc. Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
A detailed history of Cornercap Investment Counsel Inc transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 13,240 shares of ITOS stock, worth $195,687. This represents 0.03% of its overall portfolio holdings.
Number of Shares
13,240
Previous 13,240
-0.0%
Holding current value
$195,687
Previous $144,000
25.0%
% of portfolio
0.03%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding ITOS
# of Institutions
142Shares Held
30.2MCall Options Held
84.6KPut Options Held
32.2K-
Black Rock Inc. New York, NY4.11MShares$60.8 Million0.0% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$40.5 Million15.24% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2MShares$29.5 Million0.78% of portfolio
-
Boxer Capital, LLC San Diego, CA1.8MShares$26.7 Million1.28% of portfolio
-
Bio Impact Capital LLC Cambridge, MA1.75MShares$25.8 Million3.9% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $526M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...